FNCB Bancorp (NASDAQ:FNCB) reported quarterly earnings of $0.26 per share. This is a 30 percent increase over earnings of $0.20 per share from the same period last year.
JP Morgan Downgrades Cyteir Therapeutics to Neutral
JP Morgan analyst Anupam Rama downgrades Cyteir Therapeutics (NASDAQ:CYT) from Overweight to Neutral.